US Patent Issued to Helio Health, The Regents of the University of California on July 15 for "Lung cancer methylation markers and uses thereof" (Chinese, American Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,359,258, issued on July 15, was assigned to Helio Health Inc. (Irvine, Calif.) and The Regents of the University of California (Oakland, Calif.).

"Lung cancer methylation markers and uses thereof" was invented by Kang Zhang (San Diego), Rui Hou (Shenyang, China) and Lianghong Zheng (Shenyang, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are methods and kits for identifying a subject as having lung cancer. Also provided herein are methods and kits for determining the prognosis of a subject having lung cancer and for determining the progression of lung cancer in a subject."

The patent was filed on July 6, 2017, under Application ...